Convergent Genomics’ UroAmp genomic urine test for bladder cancer will be the subject of two new studies being presented at the 2023 American Urological Association Annual Meeting.
Read More
New technology detects bladder cancer in both the clinic and operating room settings by using blue and white light, and an imaging dye.
Read More
A collaboration between University of Birmingham and Nonacus has resulted in a novel test for the non-invasive detection of bladder cancer.
Read More
Data shows a link between tumor DNA circulating in blood and patient responses to investigational neoadjuvant treatment with immune therapies
Read More
Techcyte and Cytobay are collaborating on a non-invasive test aimed at enhancing bladder cancer surveillance.
Read More